Ernest Schneider

Ernest Schneider is a solicitor, patent & trade mark attorney and accredited mediator. He is the Commercial-Legal Director and Company Secretary of NetScientific plc and joined the ProAxsis Board in January 2016.

He was a partner with two large London law firms after which he established a successful international niche intellectual property firm.  Ernest has negotiated and drafted numerous technology cross-licence, joint venture and M&A agreements.  He has masterminded, put in place and maintained a worldwide licensing programme with hundreds of patent licence agreements. He has enforced, defended and challenged intellectual property rights around the world, conducting litigation, arbitration and mediation in most countries in Europe and in the USA, Canada, Hong Kong, Australia and New Zealand. Interwoven with his legal practice, Ernest has held executive and non-executive directorships and chairmanships in industry. He also has personal entrepreneurial experience, having set up and shut down a couple of business ventures of his own.

Ernest grew up in Lancaster, Florida and Luxembourg where he took his baccalauréat in sciences. He obtained his first degree in economics from Lancaster University Management School and then read law and postgraduate EU law at Leeds Business School.  He is fluent in French, German and Lëtzebuergesch, has fluent but colloquial Hungarian and useful intermediate Spanish.

Ernest Schneider

Non-executive Director
Ernest Schneider
Dr David Ribeiro

Dr David Ribeiro

CEO
Dr Ribeiro has extensive experience in commercialising products within chronic diseases, having previously held senior management roles at Solvay Healthcare, Encysive Pharmaceuticals and Pfizer.
Read More
François Martelet

François Martelet

Chairman
François Martelet brings over 20 years of biopharma experience and a proven track record of shaping and developing businesses to deliver returns. He has broad
Read More
Brian Walker

Brian Walker

CSO
Professor Walker has over 30 years experience in the design & synthesis of “Protease-Tags” for the identification and validation of protease targets of biomedical and
Read More
Ian Postlethwaite

Ian Postlethwaite

Non-executive Director
Ian Postlethwaite brings over 14 years of biopharma experience and a proven track record of driving revenue growth and funding development programs. He has broad
Read More
David Moore

David Moore

Head of Spin Outs & Investments, QUBIS Ltd.
David is Investment Manager with QUBIS Ltd, the early stage investment fund responsible for the commercialisation of technology from The Queen’s University of Belfast.
Read More
Lorraine Martin

Lorraine Martin

Non-executive Director
Dr Lorraine Martin is a co-founder of ProAxsis Ltd. and a Senior Lecturer in Molecular Pharmaceutics within the School of Pharmacy, Queen’s University Belfast.
Read More